An alternative perspective to the immune response in autoimmune exocrinopathy: Induction of functional quiescence rather than destructive autoaggression

Scandinavian Journal of Immunology

Volumn 49, Issue 1, 1999, Pages 07-10

  Humphreys Beher, Michael G ^a,b   Brayer, J ^a   Yamachika, S ^a   Peck, A B ^a,b   Jonsson, R ^c  

^a UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

MUSCARINIC M3 RECEPTOR; RECEPTOR ANTIBODY;

APOPTOSIS; AUTOIMMUNITY; CELL INFILTRATION; CELL PROLIFERATION; CLINICAL FEATURE; HUMAN; IMMUNOPATHOGENESIS; LACRIMAL GLAND; MONONUCLEAR CELL; PRIORITY JOURNAL; REVIEW; SALIVARY GLAND; SALIVATION; SECOND MESSENGER; SJOEGREN SYNDROME; TEAR FLOW;

EID: 0032922036     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1999.00490.x     Document Type: Review

References (31)

1. 1 Fox RI, Tornwall J, Maruyami T, Stern M. Sjögren's syndrome: evolving concepts of diagnosis, pathogenesis and therapy. Current Opinion Rheumatol 1998 (in press).
2. 2 Andoh Y, Shimura S, Sawai T, Saski H, Takishima T, Shirato K. Morphometric analysis of secretory glands in Sjögren's syndrome. Tohoku J Exp Med 1993;146:1358-62.
3. 3 Jonsson R, Kroneld U, Tarkowski A. Histologic and functional features of salivary glands in rheumatic patients with oral sicca symptoms. Scand J Rheumatol 1988;17:387-91.
4. 4 Jonsson R, Kroneld U, Bäckman K, Magnusson B, Tarkowski A. Progression of sialadenitis in patients with Sjögren's syndrome. Brit J Rheumatol 1993;32:578-81.
5. 5 Fox RI. Sjögren's syndrome. Controversies and Progress. Clin Lab Med 1997;17:431-44.
6. 6 Soliven B, Wang N. Tumor necrosis factor alpha regulates responses of cultures of sympathetic neurons and non-neuronal cells. J Neurochem 1995;634:883-94.
7. 7 Campbell IL, Chiang CS. Cytokine involvement in central nervous system disease. Implications from transgenic mice. Ann N Y Acad Sci 1995;771:301-12.
8. 8 Wu AJ, Chen ZJ, Kan EC, Baum BJ. Interferon-γ-induced JAK2 and STAT1 signalling in a human salivary gland cell line. J Cell Physiol 1997;173:110-4.
9. 9 Wu AJ, Kurrasch RH, Katz J, Fox PC, Baum BJ, Atkinson JC. Effect of tumor necrosis factor-α and interferon-γ on the growth of a human salivary gland cell line. J Cell Physiol 1994;161:217-26.
10. 10 Wu AJ, Chen ZJ, Tsokos M, O'Connell BC, Ambudkar IS, Baum BJ. Interferon-γ induced cell death in a cultured human salivary gland cell line. J Cell Physiol 1996;167:297-304.
11. 11 Bacman S, Sterin-Borda L, Camusso JJ, Arana R, Hubscher O, Borda E. Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjögren's syndrome. Clin Exp Immunol 1996;104:454-9.
12. 12 Bacman S, Perez Leiros C, Sterin-Borda L, Hubscher O, Arana R, Borda E. Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome. Invest Ophthalmol Vis Sci 1998;39:151-6.
13. 13 Borda E, Camusso JJ, Perez Leiros C et al. Circulating antibodies against neonatal cardiac muscarinic acetylcholine receptor in patients with Sjögren's syndrome. Mol Cell Biochem 1996;163:335-41.
14. null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren's syndrome. Proc Natl Acad Sci (USA) 1998;95:7538-43.
15. 15 Yamamoto H, Simms NE, Macauley SP et al. Alterations in the secretory response of non-obese diabetic (NOD) mice to muscarinic receptor stimulation. Clin Immunol Immunopathol 1996;78:245-55.
16. 16 Hu Y, Purushotham KR, Wang P, Dawson R Jr, Humphreys-Beher MG. Downregulation of beta-adrenergic receptors and signal transduction response in salivary glands of NOD mice. Am J Physiol 1994;266:G433-G443.
17. 17 Fox PC. Saliva composition and its importance in dental health. Compend Contin Edu Dent Suppl 1989;13:S456-S460.
18. 18 Herrera JL, Lyons MFII, Johnson LF. Saliva: its role in health and disease. J Clin Gastroenterol 1988;10:569-78.
19. 19 Baum BJ, Dai Y, Hiramatsu Y, Horn VJ, Ambudkar IS. Signaling mechanisms that regulate saliva formation. Crit Rev Oral Biol Med 1993;4:379-84.
20. 20 Quissell DO, Watson E, Dowd FJ. Signal transduction mechanisms involved in salivary gland regulated exocytosis. Crit Rev Oral Biol Med 1992;3:83-107.
21. 21 Lucas M, Sanchez-Margalet V. Review: protein kinase C involvement in apoptosis. Gen Pharmacol 1995;26:881-7.
22. 22 Leszezynski Y. The role of protein kinase C in regulation of apoptosis: a brief overview of the controversy. Cancer J 1996;9:301-13.
23. 23 Hausdorff WP, Caron MG, Letkowitz RJ. Turning off the signal: desensitization of ïïb-adrenergic function. FASEB J 1990;4:2881-9.
24. 24 Merry DE, Korsmeyer SJ. BCL-2 gene family in the nervous system. Ann Rev Neurosci 1997;20:245-67.
25. 25 Törnwall J, Konttinen YT, Tournenin RK, Törnwall M. Protein kinase C expression in salivary gland acinar epithelial cells in Sjögren's syndrome. Lancet 1997;349:1814-5.
26. 26 Konttinen YT, Sorsa T, Hukkanen M et al. Topology of innervation of labial salivary glands by protein gene product 9.5 and synaptophysin immunoreactive nerves in patients with Sjögren's syndrome. J Rheumatol 1992;19:30-7.
27. 27 Konttinen YT, Hukkanen M, Kemppinen P et al. Peptide containing nerves in labial salivary glands in Sjögren's syndrome. Arthritis Rheum 1992;35:815-20.
28. 28 Robinson CP, Yamachika S, Alford CE et al. Elevated levels of cysteine protease activity in the saliva and salivary glands of the NOD mouse model for Sjögren's syndrome. Proc Natl Acad Sci USA 1997;94:5767-71.
29. 29 Robinson CP, Yamamoto H, Peck AB, Humphreys-Beher MG. Genetically programmed development of salivary gland abnormalities in the NOD (non-obese diabetic) -scid mouse in the absence of detectable lymphocytic infiltration: a potential trigger of sialoadentitis of NOD mice. Clin Immunol Immunopathol 1996;79:50-9.
30. 30 Muir A, Peck A, Clare-Salzer M et al. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-γ transcription. J Clin Invest 1995;95:628-34.
31. 31 Weiner HL. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 1997;18:335-43.